1603-03-8

Usage

Uses

Used in Pharmaceutical Industry:
15-METHYLHEXADECANOIC ACID is used as a pharmaceutical compound for its potential therapeutic applications. The expression is: 15-METHYLHEXADECANOIC ACID is used as a therapeutic agent for its unique chemical properties and presence in various natural sources, which may contribute to its potential benefits in medical applications.
Used in Nutritional Supplements:
In the nutritional supplement industry, 15-METHYLHEXADECANOIC ACID is used as an ingredient in supplements for its potential health benefits. The expression is: 15-METHYLHEXADECANOIC ACID is used as a supplement ingredient for its presence in natural sources like human breast milk, which may suggest its importance in early human development and overall health.
Used in Cosmetics:
15-METHYLHEXADECANOIC ACID is used in the cosmetics industry for its potential benefits in skincare products. The expression is: 15-METHYLHEXADECANOIC ACID is used as an ingredient in cosmetics for its potential moisturizing and skin-conditioning properties, which may contribute to improved skin health and appearance.
Used in Research:
In the research field, 15-METHYLHEXADECANOIC ACID is used as a subject of study for its unique chemical structure and potential applications in various scientific disciplines. The expression is: 15-METHYLHEXADECANOIC ACID is used as a research subject for its potential to contribute to the understanding of fatty acid metabolism, biochemistry, and other related fields.

InChI:InChI=1/C17H34O2/c1-16(2)14-12-10-8-6-4-3-5-7-9-11-13-15-17(18)19/h16H,3-15H2,1-2H3,(H,18,19)

Upstream product

• 1070-62-8 5-ethoxy-5-oxopentanoic acid 
• 2724-57-4 isomyristic acid 
• 3344-77-2 12-bromododecanol 
• 107-82-4 i-pentyl bromide 
• 51166-20-2 15-methylhexadecan-1-ol 
• 728935-75-9 15-methylhexadecan-1,15-diol 
• 412033-57-9 15-hydroxy-15-methyl-hexadecanoic acid 
• 101883-02-7 (+/-)-16-methyl-heptadecane-1,2,16-triol 
• 101592-33-0 15-bromo-15-methyl-hexadecanoic acid 

Downstream Products

• 6929-04-0 15-methylhexadecanoic acid methyl ester 
• 1446749-30-9 C₂₇H₄₆O₄ 

Relevant academic research and scientific papers

COMPOSITIONS IN THE FORM OF AN INJECTALE AQUEOUS SOLUTION COMPRISING HUMAN GLUCAGON AND A CO-POLYAMINO ACID

Physically stable compositions in the form of an injectable aqueous solution, the pH of which is comprised from 6.0 to 8.0, having at least: human glucagon and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals Hy, in one embodiment, the compositions according to the invention further includes a gastrointestinal hormone.

COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN RECEPTOR AGONIST OR AN AMYLIN ANALOGUE AND A CO-POLYAMINO ACID

A composition in the form of an injectable aqueous solution, the pH of which is comprised from 6.0 to 8.0, including at least: a) amylin, an amylin receptor agonist or an amylin analogue;b) a co-polyamino acid bearing carboxylate charges and hydrophobic radicals Hy, said co-polyamino acid being constituted of glutamic or aspartic units and said hydrophobic radicals Hy being according to formula I below: [in-line-formulae]*?GpR?r?GpA?a?GpC)p ??Formula I[/in-line-formulae] wherein the composition does not comprise a basal insulin the isoelectric point pI of which is comprised from 5.8 to 8.5. It also relates to a composition wherein it further includes prandial insulin.

COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN RECEPTOR AGONIST OR AN AMYLIN ANALOG, AND A CO-POLYAMINO ACID

An injectable aqueous solution, of which the pH is from 6.0 to 8.0, comprising at least: a) amylin, an amylin receptor agonist or an amylin analog; b) a co-polyamino acid bearing carboxylate charges and hydrophobic radicals Hy, said co-polyamino acid consisting of glutamic or aspartic units and said hydrophobic radicals Hy having the following formula I: [in-line-formulae]?GpR?r?GpA?a?GpC)p ??I[/in-line-formulae] wherein the composition does not comprise a basal insulin of which the isoelectric point pI is from 5.8 to 8.5. It also relates to a composition wherein it moreover comprises a prandial insulin.

Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid

An injectable aqueous solution, the pH of which is from 6.0 to 8.0, having at least: a) human glucagon, and b) a co-polyamino acid bearing carboxylate charges and hydrophobic radicals Hy. In an embodiment, the compositions have, in addition, a gastrointestinal hormone.

A practical synthesis of long-chain iso-fatty acids (iso-C 12-C19) and related natural products

A gram-scale synthesis of terminally-branched iso-fatty acids (iso-C 12-C19) was developed commencing with methyl undec-10-enoate (methyl undecylenate) (for iso-C12-C14) or the C15 and C16 lactones pentadecanolide (for iso-C 15-C17) and hexadecanolide (for iso-C18-C 19). Central to the approaches outlined is the two-step construction of the terminal isopropyl group through addition of methylmagnesium bromide to the ester/lactones and selective reduction of the resulting tertiary alcohols. Thus, the C12, C17 and C18 iso-fatty acids were obtained in three steps from commercially-available starting materials, and the remaining C13-C16 and C19 iso-fatty acids were prepared by homologation or recursive dehomologations of these fatty acids or through intercepting appropriate intermediates. Highlighting the synthetic potential of the iso-fatty acids and various intermediates prepared herein, we describe the synthesis of the natural products (S)-2,15-dimethylpalmitic acid, (S)-2-hydroxy-15-methylpalmitic acid, and 2-oxo-14-methylpentadecane.

METHOD FOR PRODUCING CROSS-COUPLING COMPOUND

To provide a method for performing a cross-coupling reaction of a Grignard compound with an alkyl halide simply, efficiently and in high yield, a method for obtaining a ω-bromo long chain carboxylic acid simply and efficiently using an easily obtainable raw material and a method for producing a useful branched fatty acid simply and efficiently. [R1: an alkyl group having 1 to 15 carbon atoms, R2: an alkyl group having 1 to 30 carbon atoms with a carboxyl group and X and X': a halogen atom] [n : an integer of 9 to 17] [n : an integer of 9 to 17, R1a : a branched alkyl group having 3 to 8 carbon atoms and X: a halogen atom]